Infections Streptococcal
📧 Sign up to get email alerts when something new happens for Infections Streptococcal.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-25Clinical Trial Update: Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease [Phase 3]
Phase 3 trial evaluating GSK's pneumococcal conjugate vaccine 1024850A for effectiveness against invasive pneumococcal disease; trial comple…
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Identification and Characterization of Bacteria in the Lungs of Children From 6 Months up to 6 Years Old, With Suspected Infection of the Lungs, in Spain. [NA]
A completed clinical trial conducted in Spain investigated identification and characterization of bacteria in the lungs of young children wi…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment [Phase 4]
Phase 4 trial updating primary and booster vaccination with GSK1024850A and prophylactic antipyretic treatment; study completed with results…
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 immunogenicity and safety study of GSK's 10-valent pneumococcal conjugate vaccine has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-01-14Clinical Trial Update: Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines [Phase 3]
Phase 3 clinical trial update on a pneumococcal vaccine booster in healthy children aged 12-18 months previously primed with the same vaccin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-14Clinical Trial Update: Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali [Phase 3]
Phase 3 clinical trial update on immunization of children previously primed with GSK pneumococcal vaccine GSK1024850A and unprimed children …
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 safety and immunogenicity trial update for GSK's 10-valent pneumococcal conjugate vaccine has completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-12-14Clinical Trial Update: Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A [Phase 3]
Phase 3 trial evaluating a pneumococcal vaccine (GSK1024850A) in primed and age-matched unprimed children; study completed with results post…
-
CLINICAL_TRIALS trial_result · 2017-10-06Clinical Trial Update: Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination [Phase 2]
Phase 2 trial updating safety and immunogenicity of a pneumococcal vaccine in children 12-23 months at first vaccination; results completed …
-
CLINICAL_TRIALS trial_result · 2017-07-28Clinical Trial Update: Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine [Phase 2]
Phase 2 trial assessing safety and immunogenicity of liquid and lyophilized formulations of a trivalent Group B Streptococcus vaccine; resul…
-
CLINICAL_TRIALS trial_result · 2017-07-19Clinical Trial Update: Evaluation of a Booster Dose of Pneumococcal Vaccine Formulations in Young Adults [Phase 2]
Phase 2 trial evaluating a booster dose of pneumococcal vaccine formulations in young adults has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants. [Phase 3]
A Phase 3 clinical trial evaluated safety and immunogenicity of a booster dose of pneumococcal conjugate vaccine in preterm born infants; re…
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants [Phase 3]
Phase 3 trial comparing immunogenicity of a 4-dose GSK pneumococcal vaccine presentation to the licensed 1-dose Synflorix when co-administer…
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Safety & Immunogenicity of Pneumococcal Vaccine 2189242A Co-administered With DTPa-HBV-IPV/Hib in Healthy Infants [Phase 2]
Phase 2 trial evaluating safety and immunogenicity of a pneumococcal vaccine co-administered with DTPa-HBV-IPV/Hib in healthy infants; resul…
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: COMPAS (Clinical Otitis Media & Pneumonia Study): Pneumonia & Acute Otitis Media (AOM ) Efficacy Study of the Pneumococcal Conjugate Vaccine [Phase 3]
Phase 3 COMPAS study evaluating Pneumococcal Conjugate Vaccine for pneumonia and acute otitis media; study completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. [Phase 3]
Phase 3 trial update on primary and booster vaccination with a pneumococcal vaccine in diverse HIV exposure/infection statuses among infants…